494 related articles for article (PubMed ID: 23430754)
1. Combined serum CA19-9 and miR-27a-3p in peripheral blood mononuclear cells to diagnose pancreatic cancer.
Wang WS; Liu LX; Li GP; Chen Y; Li CY; Jin DY; Wang XL
Cancer Prev Res (Phila); 2013 Apr; 6(4):331-8. PubMed ID: 23430754
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA biomarkers in whole blood for detection of pancreatic cancer.
Schultz NA; Dehlendorff C; Jensen BV; Bjerregaard JK; Nielsen KR; Bojesen SE; Calatayud D; Nielsen SE; Yilmaz M; Holländer NH; Andersen KK; Johansen JS
JAMA; 2014 Jan 22-29; 311(4):392-404. PubMed ID: 24449318
[TBL] [Abstract][Full Text] [Related]
3. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma.
Zhou J; Yu L; Gao X; Hu J; Wang J; Dai Z; Wang JF; Zhang Z; Lu S; Huang X; Wang Z; Qiu S; Wang X; Yang G; Sun H; Tang Z; Wu Y; Zhu H; Fan J
J Clin Oncol; 2011 Dec; 29(36):4781-8. PubMed ID: 22105822
[TBL] [Abstract][Full Text] [Related]
4. CEACAM1, a novel serum biomarker for pancreatic cancer.
Simeone DM; Ji B; Banerjee M; Arumugam T; Li D; Anderson MA; Bamberger AM; Greenson J; Brand RE; Ramachandran V; Logsdon CD
Pancreas; 2007 May; 34(4):436-43. PubMed ID: 17446843
[TBL] [Abstract][Full Text] [Related]
5. Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer.
Liu J; Gao J; Du Y; Li Z; Ren Y; Gu J; Wang X; Gong Y; Wang W; Kong X
Int J Cancer; 2012 Aug; 131(3):683-91. PubMed ID: 21913185
[TBL] [Abstract][Full Text] [Related]
6. Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer.
Tang D; Shen Y; Wang M; Yang R; Wang Z; Sui A; Jiao W; Wang Y
Eur J Cancer Prev; 2013 Nov; 22(6):540-8. PubMed ID: 23462458
[TBL] [Abstract][Full Text] [Related]
7. Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer.
Dittmar RL; Liu S; Tai MC; Rajapakshe K; Huang Y; Longton G; DeCapite C; Hurd MW; Paris PL; Kirkwood KS; Coarfa C; Maitra A; Brand RE; Killary AM; Sen S
Cancer Prev Res (Phila); 2021 Jul; 14(7):729-740. PubMed ID: 33893071
[TBL] [Abstract][Full Text] [Related]
8. Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter study.
Cao Z; Liu C; Xu J; You L; Wang C; Lou W; Sun B; Miao Y; Liu X; Wang X; Zhang T; Zhao Y
Oncotarget; 2016 Jul; 7(27):41575-41583. PubMed ID: 27223429
[TBL] [Abstract][Full Text] [Related]
9. Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer.
Hussein NA; Kholy ZA; Anwar MM; Ahmad MA; Ahmad SM
J Cancer Res Clin Oncol; 2017 Jan; 143(1):83-93. PubMed ID: 27631726
[TBL] [Abstract][Full Text] [Related]
10. [Expression and clinical significance of plasma small RNA in patients with pancreatic cancer].
Pan W; Tang W; Yuan W; Yu Q; Zuo W; Xu C; Ma J
Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):351-4. PubMed ID: 25030590
[TBL] [Abstract][Full Text] [Related]
11. Circulating peripheral blood mononuclear cells exhibit altered miRNA expression patterns in pancreatic cancer.
Frampton AE; Fletcher CE; Gall TM; Castellano L; Bevan CL; Stebbing J; Krell J
Expert Rev Mol Diagn; 2013 Jun; 13(5):425-30. PubMed ID: 23782250
[TBL] [Abstract][Full Text] [Related]
12. A plasma microRNA panel for early detection of colorectal cancer.
Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H
Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911
[TBL] [Abstract][Full Text] [Related]
13. Altered miR-143 and miR-150 expressions in peripheral blood mononuclear cells for diagnosis of non-small cell lung cancer.
Zeng XL; Zhang SY; Zheng JF; Yuan H; Wang Y
Chin Med J (Engl); 2013 Dec; 126(23):4510-6. PubMed ID: 24286416
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers.
Kojima M; Sudo H; Kawauchi J; Takizawa S; Kondou S; Nobumasa H; Ochiai A
PLoS One; 2015; 10(2):e0118220. PubMed ID: 25706130
[TBL] [Abstract][Full Text] [Related]
15. Identification of Serum microRNA-25 as a novel biomarker for pancreatic cancer.
Yu Y; Tong Y; Zhong A; Wang Y; Lu R; Guo L
Medicine (Baltimore); 2020 Dec; 99(52):e23863. PubMed ID: 33350781
[TBL] [Abstract][Full Text] [Related]
16. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
[TBL] [Abstract][Full Text] [Related]
17. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer.
Jiang X; Du L; Wang L; Li J; Liu Y; Zheng G; Qu A; Zhang X; Pan H; Yang Y; Wang C
Int J Cancer; 2015 Feb; 136(4):854-62. PubMed ID: 24961907
[TBL] [Abstract][Full Text] [Related]
18. Decreased serum miR-181a is a potential new tool for breast cancer screening.
Guo LJ; Zhang QY
Int J Mol Med; 2012 Sep; 30(3):680-6. PubMed ID: 22692639
[TBL] [Abstract][Full Text] [Related]
19. Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9.
Koopmann J; Rosenzweig CN; Zhang Z; Canto MI; Brown DA; Hunter M; Yeo C; Chan DW; Breit SN; Goggins M
Clin Cancer Res; 2006 Jan; 12(2):442-6. PubMed ID: 16428484
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]